Benzinga

Benzinga

Benzinga

venerdì, settembre 04

Precigen Inc

PGENNASDAQ
Trade with Public
Trade with Public
$7.15
0.010.14%
Ult. Agg.: Sep 4, 1:34 PM
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Precigen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Precigen (PGEN).

Price Target Range — 11 Quarters

Analyst Consensus — 7 Analysts

3S.Buy
3Buy
1Hold
Consensus RatingMarket Outperform# Analysts7Avg. Consensus PT$10Upside to Avg. PT+37.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 5, 2026HC Wainwright & Co.Swayampakula RamakanthPT RaiseBuy$14→$18
Aug 3, 2026HC Wainwright & Co.Swayampakula RamakanthMaintainedBuy$14
More with Benzinga EdgeGet Access

Analyst Ratings News

Toast To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts changed outlook on top names. UBS cut Fidelity National Information target, JP Morgan downgraded Ball, Needham raised Hinge Health.
Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $18

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $14 to $18.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Precigen, Maintains $14 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Precigen (NASDAQ:PGEN) with a Buy and maintains $14 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $14

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $11 to $14.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on Precigen, Raises Price Target to $11

Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $9 to $11.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Precigen, Raises Price Target to $11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $10 to $11.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved